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Autosomal recessive congenital ichthyoses are a hetero-
geneous group of disfiguring skin diseases. They are
generally characterized by variable scaling and erythro-
derma, and patients are frequently collodion babies at
birth. Autosomal recessive congenital ichthyoses are
represented in 25 of our 50 families by a defective
keratinocyte transglutaminase (TGK). Pathogenic classi-
fication is difficult to assess on clinical grounds for
autosomal recessive congenital ichthyoses and impossible
for collodion babies. Thus, we have established a rapid
TGK assay in situ on frozen skin sections using incorpora-
tion of dansyl-cadaverin to assess transglutaminase (TG)
activity in combination with immunohistochemistry for
TGK protein. Results were compared with TG activity
levels measured in cultured differentiating keratinocytes.
Sixteen of 26 patients, including a collodion baby, had
strongly diminished TG activity in the cell periphery of
Autosomal recessive congenital ichthyoses (ARCI, syn.ichthyosis congenita mitis, lamellar ichthyosis, nonbull-ous congenital ichthyosiform erythroderma, MIM #242100, 242300, and 601277) are severe genodermatoseswith generalized ichthyotic scaling as their most promin-
ent feature (Traupe, 1989; Anton-Lamprecht, 1992). ARCI are clinic-
ally and genetically heterogeneous. The phenotype can range from
large brownish plate-like scales with no erythroderma (i.e., lamellar
ichthyosis) (Frost and Van Scott, 1966) to fine white scales with
underlying erythroderma (i.e., nonbullous congenital ichthyosiform
erythroderma) (Brocq, 1902). Moreover, patients may have palmar and
plantar hyperkeratosis, scarring alopecia, ectropion, eclabium, and
decreased sweating. Patients are often born encased in a shiny, thick
parchmentlike membrane (collodion baby). ARCI are rare and have
an estimated frequency of about 1:100,000–1:250,000.
Transglutaminases (TG) are a superfamily of enzymes that catalyze
transamidation of glutamine residues, a reaction associated with a wide
variety of physiologic processes such as blood clotting, cytoplasmic
coagulation in apoptosis, keratinization, hair follicle formation, and
fertilization (Greenberg et al, 1991; Polakowska and Goldsmith, 1991;
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differentiating keratinocytes and membrane-bound TG
activities in vitro, ranging from 2.2 to 281.3 pmol per h
mg. Nine of 26 patients, including a collodion baby,
showed strong TG activity in the cell periphery of differ-
entiating keratinocytes in situ and membrane-bound TG
activities in vitro ranged from 1519 to 10917 pmol per h
mg. In one case, TG assay in situ was ambiguous;
however, membranous TG activity in vitro was very low at
76.9 pmol/h 3 mg. Our results demonstrate an excellent
correlation of TG assays in vitro and in situ. In addition,
we present a novel test with prognostic value for the
collodion baby phenotype. This assay allows rapid patho-
genic classification of autosomal recessive congenital
ichthyoses with only one caveat that in rare ambiguous
cases it might be necessary for proper classification to
assess membrane-bound TG activity in vitro. Key words:
keratinocyte/lamellar ichthyosis/transglutaminase. J Invest
Dermatol 110:268–271, 1998
Aeschlimann and Paulsson, 1994). Two members of this protein family,
keratinocyte TG (TGK or TG1) and epidermal TG (TGE or TG3),
mediate Nε-(γ-glutamyl)lysine cross-linkage (Thacher and Rice, 1985;
Thacher, 1989) during formation of the cornified cell envelope (CE),
a distinct and highly insoluble structure of 8–15 nm thickness that
replaces the plasma membrane in terminally differentiating keratinocytes
(Hohl and Roop, 1993; Reichert et al, 1993). This process involves
the sequential cross-linking of CE precursor proteins such as involucrin,
cystatinA, small proline rich proteins, elafin, and loricrin on the inner
side of the plasma membrane (Hohl and Roop, 1993; Steinert and
Marekov, 1995). Simultaneously, the plasma membrane is replaced by
Ω-hydroxyacyl-sphingosine lipids covalently bound to the outer surface
of the protein CE (Wertz et al, 1989; Steinert and Marekov, 1997).
TGK is mostly expressed on the plasma membrane in upper spinous
and granular cell layers of stratified squamous epithelia (Thacher and
Rice, 1985; Thacher, 1989; Kim et al, 1995). Approximately 5–10%
of TGK activity is found in the cytoplasmic fraction and may account
for the final steps of CE cross-linkage (Thacher and Rice, 1985;
Thacher, 1989). TGK activity requires a catalytic triad (Cys, His, Asp)
arranged in the enzyme active site and is dependant on forming a
complex with calcium ions (Greenberg et al, 1991; Aeschlimann and
Paulsson, 1994; Pedersen et al, 1994). The human TGK gene contains
15 exons, is located on chromosome 14q11 (TGM1 locus), and has at
least two sequence variants (Kim et al, 1992; Phillips et al, 1992)
Recently, faulty TGK expression (Hohl et al, 1993) caused by
deleterious mutations in the TGK gene has been identified as a cause
of ARCI (Huber et al, 1995a; Parmentier et al, 1995; Russell et al,
1995), providing compelling evidence for the importance of the CE
for epidermal homeostasis and the barrier function of the skin.
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Table I. Correlation of TG assays in vivo and in vitro
Patient Cytosol pmol/h mg Membrane pmol/h mg IF
LI-1.5 13.9 6 7.6 (2) 44.6 6 24.2 (2) neg
LI-3.7 34.5 6 2.5 (2) 76.9 6 24.6 (2) pos?
LI-3.8 26.3 6 9.7 (2) 37.2 6 22.8 (2) neg
LI-5.3 208.8 6 1.3 (2) 3837.2 6 24.1 (2) pos
LI-8.3 5.8 6 1.2 (3) 13.9 6 4.5 (3) neg
LI-12.6 458.2 6 1.3 (2) 1519.4 6 225.6 (2) pos
LI-20.1 166.0 6 89.7 (2) 175.4 6 62.1 (2) neg
LI-20.3 2 6 1.1 (2) 2.2 6 0.4 (2) neg
LI-20.4 5.6 6 2.1 (2) 4 6 2.6 (2) neg
LI-22 4 6 2.4 (2) 52.2 6 11.0 (3) neg
LI-23 37.9 6 23.8 (3) 166.2 6 51.7 (2) neg
LI-24.3 2869.8 (1) 10917.7 6 1797 (2) pos
LI-24.4 2555.7 (1) 10719.7 6 3626 (2) pos
LI-27 684.3 (1) 5851.9 6 1338 (2) pos
LI-28 18.5 (1) 40.6 6 2.5 (2) neg
LI-30 8.5 64.6 (2) 31.9 6 28.8 (2) neg
LI-33 428.1 6 306.4 (2) 7502.1 6 4991 (2) pos
LI-35 620.6 6 399.5 (2) 6482.3 6 2831 (2) pos
LI-36 183.6 6 4.2 (2) 1973.9 6 457.6 (2) pos
LI-38 9.1 6 6.4 (2) 152.8 6 118.5 (2) neg
LI-39 42.9 (1) 180.4 (1) neg
LI-40 632.5 (1) 6997.8 (1) pos
83 16.5 6 5.9 (2) 22.4 6 19.0 (2) neg
84 14.4 6 9.4 (2) 10.1 6 1.9 (2) neg
87 26.5 6 6.7 (2) 186.2 6 78.7 (2) neg
88 19.7 6 1.0 (2) 281.2 6 19.4 (2) neg
Molecular and biochemical data, however, have clearly shown that
about 50% of ARCI patients have normal TG activity (Huber et al,
1995b; Bale et al, 1996). Genetic heterogeneity was further supported
by mapping studies identifying a second chromosomal locus on 2q33–
35 and a third locus at a currently unknown location carrying disease-
causing genes for ARCI (Parmentier et al, 1996). Because (i) pathogenic
classification of ARCI is difficult on clinical grounds, (ii) prognosis for
the collodion baby phenotype at birth is impossible, and (iii) information
of genetic linkage analysis is mostly insufficient in small families, we
attempted to establish reliable TG assays allowing proper and rapid
classification.
MATERIALS AND METHODS
Patients Families with ARCI from Switzerland, Germany, France, Sweden,
and the United States and normal volunteers from Switzerland were investigated
(Table I). LI-5.3 and LI-8.3 were from those of collodion babies at the time
of biopsy.
Cell culture Punch biopsies obtained from the trunk or proximal extremities
of the probands were used to establish primary cultures of keratinocytes on
lethally irradiated murine 3T3 fibroblasts (Huber et al, 1995a). Secondary
cultures were grown in high calcium keratinocyte medium supplemented with
10% fetal calf serum. Five days post-confluency, total RNA and proteins were
extracted for northern blot analysis and measuring TG activity as described below.
TG activity Cells were lysed by sonification in 20 mM sodium phosphate
pH 7.2, 0.5 mM ethylenediamine tetraacetic acid (EDTA), 10 mM dithiothreitol,
50 µg phenylmethylsulfonylfluoride per ml (cytosol fraction). After centrifuga-
tion at 25,000 3 g at 4°C for 30 min, the pellet was re-extracted by sonification
with the same buffer supplemented with 1% TritonX-100. Following incubation
for 10 min at 37°C, the lysate was centrifuged as above and the supernatant
(membrane fraction) collected for measuring the TG activity as described
previously (Lichti et al, 1985; Huber et al, 1995a). Briefly, 5 µl of cell extract
was added to 95 µl of the following freshly prepared solution: 10 µl of 0.5 M
sodium borate pH 9, 5 µl of 10 mM EDTA pH 8, 5 µl of 100 mM CaCl2,
20 µl of dimethylcasein (10 mg per ml), 2.5 µl of 10% Triton X-100, 0.5 µl
of 1 M dithiothreitol, 2.8 µl of 100 µM putrescine, 1 µl of [1,4 (n)-3H]putrescine
dihydrochloride (1 mCi per ml, 10–30 Ci per mmol; NEN), and 48.2 µl H2O.
After incubation for 30 min at 28°C, 60 µl were applied to 3 MM cellulose
filter paper (Whatman, Maidstone, U.K.), and washed sequentially in 10%
trichloroacetic acid and 0.1% putrescine, 5% trichloroacetic acid and 0.05%
putrescine, and 95% EtOH. We observed that the reaction is linear under these
conditions; less than 5% of putrescine is utilized during the incubation. TG
activity is expressed as pmol [3H]putrescine incorporated into dimethylcaseine
per h and mg protein. Results are shown as the mean of duplicate measurements
performed on cell extracts from two cell passages.
Immunofluorescence Frozen sections were incubated in 100 mM Tris-Cl
pH 8, 1% bovine serum albumin (BSA) for 30 min (to block nonspecific
binding), and then in 100 mM Tris-Cl pH 8, 5 mM CaCl2, 12 µM
monodansylcadaverine for 1 h (to detect TG activity) (Aeschlimann et al, 1993).
For a negative control in normal human skin, EDTA was added to a final
concentration of 20 mM. After stopping the TG reaction in phosphate-buffered
saline (PBS), 10 mM EDTA, sections were incubated with rabbit anti-dansyl
antibody (1:100) (Aeschlimann et al, 1993) and monoclonal anti-TGK antibody
B.C1 (1:1) (Thacher and Rice, 1985) in 12% BSA/PBS for 3 h. Sections were
then incubated with biotinylated horse anti-mouse antibody (1:100) in 12%
BSA/PBS and normal horse serum (1:100) for 30 min, followed by fluoroscein
isothiocyanate labeled swine anti-rabbit antibody (1:40) and TexasRed streptavi-
din (1:400) in 12% BSA/PBS for 30 min. Reading and interpretation was
performed by two independant observers.
RESULTS
In vitro TG assay TG activities were measured in extracts obtained
from well-differentiated cultured keratinocytes. The degree of differen-
tiation was assessed by measuring involucrin mRNA levels in cells
cultured under the same conditions as those used for determination of
TG activities. Results from our 26 ARCI patients (see Table I) showed
two obvious groups: one with low activities ranging from 2.2 to
281.3 pmol/h 3 mg with a mean 6 SEM of 87.0 6 20.6 pmol/h 3
mg (5 TGK– ARCI) and the other with high activities ranging from
1519 to 10917 pmol/h 3 mg with a mean 6 SEM of
6200 6 1122 pmol/h 3 mg (5 TGK1 ARCI). Various TGK mutations
were identified in all 13 TGK– ARCI patients analyzed by SSCP and
DNA sequencing, but no mutations were observed in the three patients
analyzed in the TGK1 ARCI patients. A control group of seven
normal healthy individuals showed values ranging from 3662 to
5030 pmol/h 3 mg with a mean 6 SEM of 4179 6 193 pmol/h 3
mg. Statistical analysis using the unpaired Student’s t test showed that
values from both the TGK1 ARCI group and the healthy individuals
were significantly different from the TGK– ARCI group (p , 0.0001).
No significant statistical difference was identified between the TGK1
ARCI group and the healthy individuals.
In situ TG assay Analysis of normal human skin revealed the
feasibility of the new TG assay in situ: after TGK activation by a
high calcium buffer in the presence of dansylcadaverine, anti-dansyl
antibodies decorated the cell periphery of keratinocytes in the middle
stratum granulosum and more diffusely in the stratum corneum (Fig 1A)
expressing TGK protein (Fig 1B). It is interesting to note that two
separate layers exhibited this activity. Addition of high amounts of
EDTA to block TG activity concomitantly with the addition of the
substrate leads to a drastic reduction of dansyl-cadaverin incorporation
(Fig 1C), whereas the protein staining pattern remained unchanged
(Fig 1D).
Much higher levels of cross-linkage of dansyl-cadaverin and expres-
sion of TGK were observed in epidermis from all TGK1 ARCI cases
in vitro. TG activity (Fig 2A) and TGK protein (Fig 2B) were
predominantly located on cell peripheries in upper spinous and granular
layers but homogeneously distributed in the stratum corneum. In
contrast, in eight of 17 TGK– ARCI individuals in vitro, TG activity
was restricted to the stratum corneum (Fig 2C) and no TGK protein
was detected (Fig 2D). Eight of 17 TGK– ARCI cases were more
difficult to interpret when slight staining for activity extended into the
malpighian layers (Fig 3A) but no TGK protein was detected (Fig 3B).
Interpretation was most difficult in one case (LI-3.7, see Table I) that
exhibited a staining pattern of in situ TG activity and TGK protein
(Fig 3C, D) comparable with normal human skin (Fig 1A, B).
DISCUSSION
Clinical classification of ARCI is controversial and reliable tools for
clinical distinction of subtypes corresponding to pathogenic entities are
actually lacking. Some authors have distinguished two subtypes, lamellar
ichthyosis and nonbullous congenital ichthyosiform erythroderma
(Williams and Elias, 1984; Traupe, 1989); however, both erythrodermic
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Figure 1. EDTA inhibits TG activity but not TGK protein expression.
Analysis of normal human skin with anti-dansyl antibodies (A, C) and anti-
TGK antibodies (B, D). EDTA added with the substrate leads to a drastic
reduction of incorporation of dansyl-cadaverin (C).
Figure 2. TGK deficiency is readily recognizable in situ. Analysis of skin
from LI-24.4 (A, B) and LI-8.3 (C, D) with anti-dansyl antibodies (A, C) and
anti-TGK antibodies (B, D). Incorporation of dansyl-cadaverin and expression
of TGK is much higher in TGK1 ARCI cases (A, B).
and nonerythrodermic patients with lamellar ichthyosis were found
among TGK– ARCI cases (Huber et al, 1995a). Moreover, recent
molecular studies have indicated at least three disease-causing genes
(Parmentier et al, 1996), and earlier ultrastructural studies suggested
perhaps even up to four or five different types of ichthyosis congenita,
indicating more complex heterogeneity (Anton-Lamprecht, 1992). In
this study, we describe reliable and rapid biochemical tools for proper
pathogenic classification of TGK– ARCI cases, which account for 50%
of all ARCI pedigrees analyzed in our series.
Figure 3. Analysis of uninvolved skin in situ may cause errors. Analysis
of skin from LI-20.1 (A, B) and LI-3.7 (C, D) with anti-dansyl antibodies (A,
C) and anti-TGK antibodies (B, D). LI-3.7 shows similar staining as normal
human skin.
The TG assay in vitro (and also immunoblotting with the monoclonal
antibody B.C1 to TGK, data not shown) can be considered as a gold
standard for defining TGK– ARCI cases biochemically. TGK– and
TGK1 ARCI cases are clearly distinct with a more than 5-fold
difference between the highest value in the TGK– ARCI group and
the lowest value in the TGK1 ARCI group. The large variability of
values measured within both groups may in part be due to the difficulty
of standardizing keratinocyte differentiation in cell culture, because of
different biopsy sites, different ages of patients, and distinct genetic
backgrounds. The much wider spread of values in the TGK– ARCI
group (128-fold for TGK– ARCI versus 7.2-fold for TGK1 ARCI)
nevertheless indicates clear differences in retained TG activities between
different TGK mutants. This interpretation is supported by the pseudo-
dominant pedigree LI-20. In this case, the affected mother LI-20.1
carried a different mutant allele and had a clearly higher TG activity
than her two affected children that had identical TGK mutants and
very similar TG activities. Furthermore, expression of different TGK
mutants in identical TGK– keratinocytes showed differences in their
intrinsic activities, indicating that the remaining activity of each mutant
is an inherent property of the position and nature of the mutation
(Huber et al, 1997).
Our TG assay in situ showed an excellent correlation with the results
from the cell cultures. Interpreting the activity assay required some
experience due to the variable expression of the different TG through-
out the epidermis. Weak TG activity and TGK protein expression was
retained in the malpighian layers in situ in eight of 17 cases of the
ARCI group TGK– in vitro (Fig 3A, B); however, this staining did
not lead to false-positive results by two independent observers. The
activity retained in the stratum corneum in all TGK– ARCI cases
(Fig 2C) is probably caused by TGE activity (Park et al, 1988; Kim
et al, 1993, 1994). As the staining of the stratum corneum in normal
human skin was abolished by depletion of calcium (EDTA treatment;
see Fig 1C), nonspecific background staining is unlikely. Two reasons
may contribute to the difficulties encountered with the biopsy from
LI-3.7. This patient was previously reported to carry three point
mutations and is one of the rare TGK– ARCI patients expressing low
levels of TGK protein detectable by immunoblotting with monoclonal
antibody B.C1 (Huber et al, 1995a). Moreover, only tissue material
from uninvolved skin was available for analysis. The drastic reduction
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of TG activity in this patient only became apparent in cell cultures
most likely due to the hyperproliferative conditions in vitro. The false-
positive interpretation of TGK activity in situ could have been evaded
by the use of involved acanthotic epidermis, as indicated by the correct
interpretation of the biopsy obtained from the sister LI-3.8 carrying
the same mutations. This seems to be a unique case/situation because
we have never had similar difficulties in affected acanthotic epidermis.
In conclusion, we describe a reliable and rapid in situ TG assay that
can be used as a diagnostic tool in dermatologic routine for ARCI and
for collodion babies. We strongly recommend the use of involved skin
for the assay in situ. If this is not possible, TG activity should be
measured from differentiating keratinocyte cultures.
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